Primary Care Clinics in Yellville, AR Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Baxter Health Ahrens Family Clinic Family Medicine Medicare: Medicare Enrolled Practice Location: 414 W Old Main St, Yellville, AR 72687 Phone: 870-449-4221 Fax: 870-449-6777 |
Ahrens Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 414 W Old Main St, Yellville, AR 72687 Phone: 870-449-4221 Fax: 870-449-6777 |
Boston Mountain Rural Health Center, Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 1201 North Panther Ave # 3, Yellville, AR 72687 Phone: 870-449-7000 Fax: 870-449-7010 |
Duffy Chiropractic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 416 Highway 62 E, Yellville, AR 72687 Phone: 870-449-2888 |
Boston Mountain Rural Health Center Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 358 East Valley St., Yellville, AR 72687 Phone: 870-449-7000 Fax: 870-449-7010 |
Kidspiration Of Marion County Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 81 Development Dr, Yellville, AR 72687 Phone: 870-449-7050 Fax: 870-424-4112 |
Baxter County Regional Hospital, Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 414 W Old Main St, Yellville, AR 72687 Phone: 870-449-4221 Fax: 870-449-6777 |
News Archive
Combination of X-rays and AI can serve as rapid diagnostic tool for COVID-19
X-rays, first used clinically in the late 1890s, could be a leading-edge diagnostic tool for COVID-19 patients with the help of artificial intelligence, according to a team of researchers in Brazil who taught a computer program, through various machine learning methods, to detect COVID-19 in chest X-rays with 95.6 to 98.5% accuracy.
Allergan, Serenity Pharmaceuticals announce global agreement for nocturia drug development
Allergan, Inc. and Serenity Pharmaceuticals, LLC today announced a global agreement for the development and commercialization of Ser-120, a Phase III investigational drug currently in clinical development for the treatment of nocturia, a common yet often under-diagnosed urological disorder in adults characterized by frequent urination at night time.
mtm laboratories signs additional tranche of Euro 7 million to its Series C funding
mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company's last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.
Levels of mitochondrial DNA in the blood may predict chronic kidney disease risk
The health of blood cells' energy-producing mitochondria may predict a person's risk of developing chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
› Verified 5 days ago